Compounded "semaglutide" is not FDA approved semaglutide.com FDA Moves to Reevaluate Several Peptides American Med Spa Association The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking FDA moves toward easing restrictions on certain peptides BioPharma Dive